Nathan Wong/LinkedIn
Mar 27, 2026, 16:23
Nathan Wong: Lp(a) Testing as a Class I Recommendation in 2026 Guidelines
Nathan Wong, Professor and Director of the Heart Disease Prevention Program, Division of Cardiology at UC Irvine, shared a post on LinkedIn:
“Today is Lp(a) Awareness Day and testing it at least once in all adults is now a Class I recommendation from the new 2026 ACC/AHA/Multisociety Dyslipidemia Guideline and there’s a lot we can do to lower risk in those with elevated levels.”
American College of Cardiology shared a post on LinkedIn:
“Learn about the unique role of Lp (a) as a genetic determinant for ASCVD risk and the importance of testing for Lp (a) levels to better understand your patients’ cardiovascular health with ACC’s online course.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers